In order to verify RGS11 as a potential diagnostic and/or prognostic biomarker for lung adenocarcinoma, both specificity and sensitivity of RGS11, other R7 RGS, and their associated proteins are being estimated in a larger cohort of patients with adenocarcinoma and other subtypes of lung cancer currently. Here, CD1C is linked to lung cancer.